| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.69 | 0.006 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |